Cytotoxic T-lymphocyte protein 4
| Pathway Name | Organism |
|---|---|
| CTLA4 inhibitory signaling | Homo sapiens |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:612 | primary immunodeficiency disease | |
| DOID:684 | hepatocellular carcinoma | |
| DOID:718 | autoimmune hemolytic anemia | |
| DOID:7188 | autoimmune thyroiditis | |
| DOID:7442 | monoclonal gammopathy of uncertain significance | |
| DOID:783 | end stage renal disease | |
| DOID:8893 | psoriasis | |
| DOID:9074 | systemic lupus erythematosus | |
| DOID:9119 | acute myeloid leukemia | |
| DOID:9383 | iridocyclitis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025